annual EBITDA:
$3.44B-$3.00M(-0.09%)Summary
- As of today (April 18, 2025), BSX annual EBITDA is $3.44 billion, with the most recent change of -$3.00 million (-0.09%) on December 1, 2024.
- During the last 3 years, BSX annual EBITDA has risen by +$933.00 million (+37.17%).
- BSX annual EBITDA is now -0.09% below its all-time high of $3.45 billion, reached on December 31, 2023.
Performance
BSX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$890.00M-$164.00M(-15.56%)Summary
- As of today (April 18, 2025), BSX quarterly EBITDA is $890.00 million, with the most recent change of -$164.00 million (-15.56%) on December 1, 2024.
- Over the past year, BSX quarterly EBITDA has dropped by -$164.00 million (-15.56%).
- BSX quarterly EBITDA is now -15.56% below its all-time high of $1.05 billion, reached on September 30, 2024.
Performance
BSX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$3.73B+$7.00M(+0.19%)Summary
- As of today (April 18, 2025), BSX TTM EBITDA is $3.73 billion, with the most recent change of +$7.00 million (+0.19%) on December 1, 2024.
- Over the past year, BSX TTM EBITDA has increased by +$7.00 million (+0.19%).
- BSX TTM EBITDA is now at all-time high.
Performance
BSX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BSX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.1% | -15.6% | +0.2% |
| 3 y3 years | +37.2% | +12.1% | +27.2% |
| 5 y5 years | +58.6% | +12.1% | +27.2% |
BSX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.1% | +37.2% | -15.6% | +50.3% | at high | +49.9% |
| 5 y | 5-year | -0.1% | +145.1% | -15.6% | +531.2% | at high | +243.4% |
| alltime | all time | -0.1% | +208.8% | -15.6% | +125.8% | at high | +194.2% |
Boston Scientific EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $3.44B(-0.1%) | $890.00M(-15.6%) | $3.73B(+0.2%) |
| Sep 2024 | - | $1.05B(+30.4%) | $3.73B(+2.1%) |
| Jun 2024 | - | $808.00M(-17.6%) | $3.65B(+0.4%) |
| Mar 2024 | - | $981.00M(+11.1%) | $3.63B(+5.4%) |
| Dec 2023 | $3.45B(+25.4%) | $883.00M(-9.5%) | $3.45B(+3.9%) |
| Sep 2023 | - | $976.00M(+22.9%) | $3.32B(+13.1%) |
| Jun 2023 | - | $794.00M(0.0%) | $2.93B(+3.6%) |
| Mar 2023 | - | $794.00M(+5.3%) | $2.83B(+3.1%) |
| Dec 2022 | $2.75B(+9.4%) | $754.00M(+27.4%) | $2.75B(+10.4%) |
| Sep 2022 | - | $592.00M(-14.6%) | $2.49B(-9.1%) |
| Jun 2022 | - | $693.00M(-2.3%) | $2.74B(+7.7%) |
| Mar 2022 | - | $709.00M(+42.9%) | $2.54B(+1.4%) |
| Dec 2021 | $2.51B(+78.6%) | $496.00M(-41.0%) | $2.51B(-7.2%) |
| Sep 2021 | - | $841.00M(+68.9%) | $2.71B(+34.9%) |
| Jun 2021 | - | $498.00M(-26.2%) | $2.01B(+18.5%) |
| Mar 2021 | - | $675.00M(-2.5%) | $1.69B(+20.5%) |
| Dec 2020 | $1.41B(-35.3%) | $692.00M(+390.8%) | $1.41B(+29.3%) |
| Sep 2020 | - | $141.00M(-23.8%) | $1.09B(-17.0%) |
| Jun 2020 | - | $185.00M(-52.2%) | $1.31B(-13.8%) |
| Mar 2020 | - | $387.00M(+3.5%) | $1.52B(-18.2%) |
| Dec 2019 | $2.17B(-15.1%) | $374.00M(+2.7%) | $1.86B(-7.4%) |
| Sep 2019 | - | $364.00M(-7.8%) | $2.01B(-12.9%) |
| Jun 2019 | - | $395.00M(-45.6%) | $2.31B(-6.3%) |
| Mar 2019 | - | $726.00M(+39.1%) | $2.46B(+8.9%) |
| Dec 2018 | $2.56B(+27.5%) | $522.00M(-21.1%) | $2.26B(+4.5%) |
| Sep 2018 | - | $662.00M(+20.1%) | $2.16B(+7.8%) |
| Jun 2018 | - | $551.00M(+5.0%) | $2.01B(+14.9%) |
| Mar 2018 | - | $525.00M(+23.5%) | $1.75B(+1.2%) |
| Dec 2017 | $2.01B(+63.8%) | $425.00M(-15.8%) | $1.73B(+8.9%) |
| Sep 2017 | - | $505.00M(+73.5%) | $1.58B(+3.5%) |
| Jun 2017 | - | $291.00M(-42.4%) | $1.53B(+47.6%) |
| Mar 2017 | - | $505.00M(+77.8%) | $1.04B(+8.6%) |
| Dec 2016 | $1.23B(+204.0%) | $284.00M(-37.0%) | $955.00M(+81.6%) |
| Sep 2016 | - | $451.00M(-322.2%) | $526.00M(-610.7%) |
| Jun 2016 | - | -$203.00M(-148.0%) | -$103.00M(-124.1%) |
| Mar 2016 | - | $423.00M(-391.7%) | $427.00M(+238.9%) |
| Dec 2015 | $403.00M(-6.7%) | -$145.00M(-18.5%) | $126.00M(-207.7%) |
| Sep 2015 | - | -$178.00M(-154.4%) | -$117.00M(-151.5%) |
| Jun 2015 | - | $327.00M(+168.0%) | $227.00M(-640.5%) |
| Mar 2015 | - | $122.00M(-131.4%) | -$42.00M(-129.0%) |
| Dec 2014 | $432.00M(-45.3%) | -$388.00M(-333.7%) | $145.00M(-80.8%) |
| Sep 2014 | - | $166.00M(+186.2%) | $755.00M(-4.1%) |
| Jun 2014 | - | $58.00M(-81.2%) | $787.00M(-24.8%) |
| Mar 2014 | - | $309.00M(+39.2%) | $1.05B(+104.5%) |
| Dec 2013 | $790.00M(-125.0%) | $222.00M(+12.1%) | $512.00M(+1.0%) |
| Sep 2013 | - | $198.00M(-37.7%) | $507.00M(-366.8%) |
| Jun 2013 | - | $318.00M(-240.7%) | -$190.00M(-95.2%) |
| Mar 2013 | - | -$226.00M(-204.1%) | -$3.96B(+14.9%) |
| Dec 2012 | -$3.16B(-292.9%) | $217.00M(-143.5%) | -$3.45B(+1.5%) |
| Sep 2012 | - | -$499.00M(-85.6%) | -$3.40B(+29.3%) |
| Jun 2012 | - | -$3.46B(-1295.5%) | -$2.63B(-328.0%) |
| Mar 2012 | - | $289.00M(+8.2%) | $1.15B(-14.2%) |
| Dec 2011 | $1.64B(+1023.3%) | $267.00M(-1.1%) | $1.34B(-13.0%) |
| Sep 2011 | - | $270.00M(-17.4%) | $1.54B(-6.8%) |
| Jun 2011 | - | $327.00M(-31.9%) | $1.66B(-1.1%) |
| Mar 2011 | - | $480.00M(+2.6%) | $1.68B(-1168.2%) |
| Dec 2010 | $146.00M(-317.9%) | $468.00M(+22.2%) | -$157.00M(-90.9%) |
| Sep 2010 | - | $383.00M(+10.7%) | -$1.72B(-10.9%) |
| Jun 2010 | - | $346.00M(-125.6%) | -$1.93B(+2.8%) |
| Mar 2010 | - | -$1.35B(+23.7%) | -$1.88B(+380.3%) |
| Dec 2009 | -$67.00M(-90.4%) | -$1.09B(-732.9%) | -$391.00M(-75.3%) |
| Sep 2009 | - | $173.00M(-56.5%) | -$1.58B(+0.1%) |
| Jun 2009 | - | $398.00M(+199.2%) | -$1.58B(+4.4%) |
| Mar 2009 | - | $133.00M(-105.8%) | -$1.51B(+33.8%) |
| Dec 2008 | -$699.00M(-176.1%) | -$2.29B(-1405.7%) | -$1.13B(-237.9%) |
| Sep 2008 | - | $175.00M(-62.3%) | $820.00M(+12.6%) |
| Jun 2008 | - | $464.00M(-9.9%) | $728.00M(+4.9%) |
| Mar 2008 | - | $515.00M(-254.2%) | $694.00M(+12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $919.00M(-52.9%) | -$334.00M(-502.4%) | $616.00M(-56.3%) |
| Sep 2007 | - | $83.00M(-80.7%) | $1.41B(-15.8%) |
| Jun 2007 | - | $430.00M(-1.6%) | $1.68B(+4.6%) |
| Mar 2007 | - | $437.00M(-5.0%) | $1.60B(-5.8%) |
| Dec 2006 | $1.95B(+25.2%) | $460.00M(+32.2%) | $1.70B(-2.5%) |
| Sep 2006 | - | $348.00M(-2.5%) | $1.74B(+57.6%) |
| Jun 2006 | - | $357.00M(-33.3%) | $1.11B(-15.8%) |
| Mar 2006 | - | $535.00M(+6.4%) | $1.31B(-5.9%) |
| Dec 2005 | $1.56B(-18.6%) | $503.00M(-274.0%) | $1.40B(-2.2%) |
| Sep 2005 | - | -$289.00M(-151.2%) | $1.43B(-32.3%) |
| Jun 2005 | - | $565.00M(-8.4%) | $2.11B(+1.3%) |
| Mar 2005 | - | $617.00M(+15.3%) | $2.08B(+18.9%) |
| Dec 2004 | $1.91B(+105.8%) | $535.00M(+36.5%) | $1.75B(+21.3%) |
| Sep 2004 | - | $392.00M(-27.1%) | $1.44B(+15.2%) |
| Jun 2004 | - | $538.00M(+88.1%) | $1.25B(+36.0%) |
| Mar 2004 | - | $286.00M(+26.0%) | $921.00M(+11.9%) |
| Dec 2003 | $930.00M(+8.6%) | $227.00M(+12.4%) | $823.00M(+1.4%) |
| Sep 2003 | - | $202.00M(-1.9%) | $812.00M(-7.2%) |
| Jun 2003 | - | $206.00M(+9.6%) | $875.00M(+7.6%) |
| Mar 2003 | - | $188.00M(-13.0%) | $813.00M(+6.0%) |
| Dec 2002 | $856.00M(+39.4%) | $216.00M(-18.5%) | $767.00M(-20.8%) |
| Sep 2002 | - | $265.00M(+84.0%) | $968.00M(+15.9%) |
| Jun 2002 | - | $144.00M(+1.4%) | $835.00M(+6.4%) |
| Mar 2002 | - | $142.00M(-65.9%) | $785.00M(0.0%) |
| Dec 2001 | $614.00M(-28.3%) | $417.00M(+215.9%) | $785.00M(+27.0%) |
| Sep 2001 | - | $132.00M(+40.4%) | $618.00M(-8.3%) |
| Jun 2001 | - | $94.00M(-33.8%) | $674.00M(-15.2%) |
| Mar 2001 | - | $142.00M(-43.2%) | $795.00M(-7.1%) |
| Dec 2000 | $856.00M(-5.2%) | $250.00M(+33.0%) | $856.00M(+7.0%) |
| Sep 2000 | - | $188.00M(-12.6%) | $800.00M(+9.7%) |
| Jun 2000 | - | $215.00M(+5.9%) | $729.00M(-3.1%) |
| Mar 2000 | - | $203.00M(+4.6%) | $752.00M(-2.5%) |
| Dec 1999 | $903.00M(+45.6%) | $194.00M(+65.8%) | $771.00M(-8.2%) |
| Sep 1999 | - | $117.00M(-50.8%) | $840.00M(-1.5%) |
| Jun 1999 | - | $238.00M(+7.2%) | $853.00M(+16.7%) |
| Mar 1999 | - | $222.00M(-15.6%) | $731.00M(+17.9%) |
| Dec 1998 | $620.00M(+21.8%) | $263.00M(+102.3%) | $620.00M(+53.9%) |
| Sep 1998 | - | $130.00M(+12.1%) | $402.80M(+1.4%) |
| Jun 1998 | - | $116.00M(+4.5%) | $397.30M(-5.4%) |
| Mar 1998 | - | $111.00M(+142.4%) | $420.10M(-0.4%) |
| Dec 1997 | $509.00M(+23.6%) | $45.80M(-63.2%) | $421.90M(+8.3%) |
| Sep 1997 | - | $124.50M(-10.3%) | $389.50M(+4.1%) |
| Jun 1997 | - | $138.80M(+23.0%) | $374.10M(+6.6%) |
| Mar 1997 | - | $112.80M(+741.8%) | $350.90M(+16.0%) |
| Dec 1996 | $411.80M(+37.3%) | $13.40M(-87.7%) | $302.50M(-4.8%) |
| Sep 1996 | - | $109.10M(-5.6%) | $317.60M(+10.6%) |
| Jun 1996 | - | $115.60M(+79.5%) | $287.20M(+16.4%) |
| Mar 1996 | - | $64.40M(+126.0%) | $246.80M(-3.8%) |
| Dec 1995 | $299.90M(+115.8%) | $28.50M(-63.8%) | $256.60M(-3.5%) |
| Sep 1995 | - | $78.70M(+4.7%) | $265.90M(+21.4%) |
| Jun 1995 | - | $75.20M(+1.3%) | $219.00M(+25.5%) |
| Mar 1995 | - | $74.20M(+96.3%) | $174.50M(+34.2%) |
| Dec 1994 | $139.00M(+20.9%) | $37.80M(+18.9%) | $130.00M(+3.1%) |
| Sep 1994 | - | $31.80M(+3.6%) | $126.10M(+2.8%) |
| Jun 1994 | - | $30.70M(+3.4%) | $122.70M(+2.6%) |
| Mar 1994 | - | $29.70M(-12.4%) | $119.60M(+4.1%) |
| Dec 1993 | $115.00M(+18.1%) | $33.90M(+19.4%) | $114.90M(+6.7%) |
| Sep 1993 | - | $28.40M(+2.9%) | $107.70M(+2.7%) |
| Jun 1993 | - | $27.60M(+10.4%) | $104.90M(+4.4%) |
| Mar 1993 | - | $25.00M(-6.4%) | $100.50M(+3.1%) |
| Dec 1992 | $97.40M(+31.8%) | $26.70M(+4.3%) | $97.50M(-491.6%) |
| Sep 1992 | - | $25.60M(+10.3%) | -$24.90M(-364.9%) |
| Jun 1992 | - | $23.20M(+5.5%) | $9.40M(-77.7%) |
| Mar 1992 | - | $22.00M(-123.0%) | $42.10M(-40.4%) |
| Dec 1991 | $73.90M | -$95.70M(-259.8%) | $70.60M(-57.5%) |
| Sep 1991 | - | $59.90M(+7.2%) | $166.30M(+56.3%) |
| Jun 1991 | - | $55.90M(+10.7%) | $106.40M(+110.7%) |
| Mar 1991 | - | $50.50M | $50.50M |
FAQ
- What is Boston Scientific annual EBITDA?
- What is the all time high annual EBITDA for Boston Scientific?
- What is Boston Scientific annual EBITDA year-on-year change?
- What is Boston Scientific quarterly EBITDA?
- What is the all time high quarterly EBITDA for Boston Scientific?
- What is Boston Scientific quarterly EBITDA year-on-year change?
- What is Boston Scientific TTM EBITDA?
- What is the all time high TTM EBITDA for Boston Scientific?
- What is Boston Scientific TTM EBITDA year-on-year change?
What is Boston Scientific annual EBITDA?
The current annual EBITDA of BSX is $3.44B
What is the all time high annual EBITDA for Boston Scientific?
Boston Scientific all-time high annual EBITDA is $3.45B
What is Boston Scientific annual EBITDA year-on-year change?
Over the past year, BSX annual EBITDA has changed by -$3.00M (-0.09%)
What is Boston Scientific quarterly EBITDA?
The current quarterly EBITDA of BSX is $890.00M
What is the all time high quarterly EBITDA for Boston Scientific?
Boston Scientific all-time high quarterly EBITDA is $1.05B
What is Boston Scientific quarterly EBITDA year-on-year change?
Over the past year, BSX quarterly EBITDA has changed by -$164.00M (-15.56%)
What is Boston Scientific TTM EBITDA?
The current TTM EBITDA of BSX is $3.73B
What is the all time high TTM EBITDA for Boston Scientific?
Boston Scientific all-time high TTM EBITDA is $3.73B
What is Boston Scientific TTM EBITDA year-on-year change?
Over the past year, BSX TTM EBITDA has changed by +$7.00M (+0.19%)